{"id":"https://openalex.org/W2074573154","doi":"https://doi.org/10.1615/critrevimmunol.v21.i1-3.100","title":"Therapeutic Potential of Leukemia-Derived Dendritic Cells: Preclinical and Clinical Progress","display_name":"Therapeutic Potential of Leukemia-Derived Dendritic Cells: Preclinical and Clinical Progress","publication_year":2001,"publication_date":"2001-01-01","ids":{"openalex":"https://openalex.org/W2074573154","doi":"https://doi.org/10.1615/critrevimmunol.v21.i1-3.100","mag":"2074573154","pmid":"https://pubmed.ncbi.nlm.nih.gov/11642601"},"language":"en","primary_location":{"id":"doi:10.1615/critrevimmunol.v21.i1-3.100","doi":"https://doi.org/10.1615/critrevimmunol.v21.i1-3.100","is_oa":false,"landing_page_url":"https://doi.org/10.1615/critrevimmunol.v21.i1-3.100","pdf_url":null,"source":{"id":"https://openalex.org/S73794665","display_name":"Critical Reviews in Immunology","issn_l":"0197-3355","issn":["0197-3355","1040-8401","2162-6472"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310315730","host_organization_name":"Begell House","host_organization_lineage":["https://openalex.org/P4310315730"],"host_organization_lineage_names":["Begell House"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical Reviews\u2122 in Immunology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004302802","display_name":"David F. Claxton","orcid":"https://orcid.org/0000-0001-9209-2405","observed_orcids":["https://orcid.org/0000-0001-9209-2405"]},"institutions":[{"id":"https://openalex.org/I130769515","display_name":"Pennsylvania State University","ror":"https://ror.org/04p491231","country_code":"US","type":"education","lineage":["https://openalex.org/I130769515"]},{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David F. Claxton","raw_affiliation_strings":["Molecular Hematology and Therapy, Box 81, U.T.M.D. Anderson Cancer Center, 1515 Holcombe, Houston, TX 77030","Pennsylvania State Univ#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Hematology and Therapy, Box 81, U.T.M.D. Anderson Cancer Center, 1515 Holcombe, Houston, TX 77030","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Pennsylvania State Univ#TAB#","institution_ids":["https://openalex.org/I130769515"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112235396","display_name":"John D. McMannis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130769515","display_name":"Pennsylvania State University","ror":"https://ror.org/04p491231","country_code":"US","type":"education","lineage":["https://openalex.org/I130769515"]},{"id":"https://openalex.org/I82783531","display_name":"Penn State Milton S. Hershey Medical Center","ror":"https://ror.org/01h22ap11","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I82783531"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John McMannis","raw_affiliation_strings":["Division of Hematology/Oncology, Milton S. Hershey Medical Center, and Department of Blood and Marrow Transplantation, M. D. Anderson Cancer Center","Pennsylvania State Univ#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology/Oncology, Milton S. Hershey Medical Center, and Department of Blood and Marrow Transplantation, M. D. Anderson Cancer Center","institution_ids":["https://openalex.org/I82783531"]},{"raw_affiliation_string":"Pennsylvania State Univ#TAB#","institution_ids":["https://openalex.org/I130769515"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048913229","display_name":"Richard E. Champlin","orcid":"https://orcid.org/0000-0002-4314-5037","observed_orcids":["https://orcid.org/0000-0002-4314-5037"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard E. Champlin","raw_affiliation_strings":["Department of Hematology, University of Texas, M.D. Anderson Cancer Center, Houston, TX","Stem Cell Transplantation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, University of Texas, M.D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Stem Cell Transplantation","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113886210","display_name":"Aniruddha Choudhury","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130769515","display_name":"Pennsylvania State University","ror":"https://ror.org/04p491231","country_code":"US","type":"education","lineage":["https://openalex.org/I130769515"]},{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aniruddha Choudhury","raw_affiliation_strings":["Department of Hematology, University of Texas, M.D. Anderson Cancer Center, Houston, TX","Pennsylvania State Univ#TAB#"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology, University of Texas, M.D. Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]},{"raw_affiliation_string":"Pennsylvania State Univ#TAB#","institution_ids":["https://openalex.org/I130769515"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.0778,"has_fulltext":false,"cited_by_count":27,"citation_normalized_percentile":{"value":0.76085251,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"21","issue":"1-3","first_page":"9","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11686","display_name":"Dendrimers and Hyperbranched Polymers","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2507","display_name":"Polymers and Plastics"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/leukemia-derived-dendritic-cells","display_name":"leukemia-derived dendritic cells","score":0.9890000224113464},{"id":"https://openalex.org/keywords/dendritic-cell-immunotherapy","display_name":"dendritic cell immunotherapy","score":0.8600000143051147},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9670000076293945},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9829999804496765},{"id":"https://openalex.org/keywords/chronic-myelomonocytic-leukemia","display_name":"chronic myelomonocytic leukemia","score":1.0},{"id":"https://openalex.org/keywords/adoptive-immunotherapy","display_name":"adoptive immunotherapy","score":0.7799999713897705},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.6039999723434448}],"concepts":[{"id":"https://openalex.org/C2776960273","wikidata":"https://www.wikidata.org/wiki/Q729735","display_name":"Chronic myelogenous leukemia","level":3,"score":0.8088936805725098},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.7439241409301758},{"id":"https://openalex.org/C2777928532","wikidata":"https://www.wikidata.org/wiki/Q1088072","display_name":"Chronic myelomonocytic leukemia","level":4,"score":0.6773458123207092},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5600465536117554},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5576721429824829},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5523982048034668},{"id":"https://openalex.org/C2778170410","wikidata":"https://www.wikidata.org/wiki/Q506253","display_name":"Dendritic cell","level":3,"score":0.5291747450828552},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.30833953619003296},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.13464674353599548},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.0521874725818634}],"mesh":[{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003713","descriptor_name":"Dendritic Cells","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007938","descriptor_name":"Leukemia","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D008213","descriptor_name":"Lymphocyte Activation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1615/critrevimmunol.v21.i1-3.100","doi":"https://doi.org/10.1615/critrevimmunol.v21.i1-3.100","is_oa":false,"landing_page_url":"https://doi.org/10.1615/critrevimmunol.v21.i1-3.100","pdf_url":null,"source":{"id":"https://openalex.org/S73794665","display_name":"Critical Reviews in Immunology","issn_l":"0197-3355","issn":["0197-3355","1040-8401","2162-6472"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310315730","host_organization_name":"Begell House","host_organization_lineage":["https://openalex.org/P4310315730"],"host_organization_lineage_names":["Begell House"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical Reviews\u2122 in Immunology","raw_type":"journal-article"},{"id":"pmid:11642601","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11642601","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Critical reviews in immunology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1929583504","display_name":null,"funder_award_id":"CA-55164","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G3774884214","display_name":"THE THERAPY OF AML","funder_award_id":"P01CA055164","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2330888817","https://openalex.org/W2246326369","https://openalex.org/W2558708845","https://openalex.org/W7100294866","https://openalex.org/W2086441372","https://openalex.org/W151799953","https://openalex.org/W2350810613","https://openalex.org/W2383744700","https://openalex.org/W1996074681","https://openalex.org/W1965240192"],"abstract_inverted_index":{"Human":[0],"leukemia-derived":[1,58],"dendritic":[2,34,59],"cells":[3,11,35,45,60],"show":[4],"potential":[5],"as":[6],"tools":[7],"for":[8,61],"therapy.":[9],"Leukemic":[10],"of":[12,55,63,72],"patients":[13],"with":[14],"chronic":[15,24],"myelogenous":[16,20],"leukemia":[17,21,26],"(CML),":[18],"acute":[19],"(AML),":[22],"and":[23,37,67],"myelomonocytic":[25],"(CMML)":[27],"will":[28],"all":[29],"undergo":[30],"substantial":[31],"differentiation":[32],"toward":[33],"(DC)":[36],"may":[38],"be":[39],"used":[40],"to":[41,46],"drive":[42],"autologous":[43,73],"T":[44],"acquire":[47],"anti-leukemic":[48],"cytotoxicity.":[49],"This":[50],"article":[51],"describes":[52],"the":[53],"use":[54],"these":[56],"human":[57],"stimulation":[62],"allogeneic":[64],"donor":[65],"lymphocytes":[66],"presents":[68],"a":[69],"clinical":[70],"trial":[71],"CML":[74],"DC-stimulated":[75],"lymphocytes.":[76]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}